Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study

BACKGROUND: RAS (KRAS and NRAS) testing is required to predict anti-epidermal growth factor receptor (EGFR) treatment efficacy in metastatic colorectal cancer (CRC). Although direct sequencing (DS) with manual microdissection (MMD) is widely used, a diagnostic kit providing rapid detections of RAS m...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshino, Takayuki, Muro, Kei, Yamaguchi, Kensei, Nishina, Tomohiro, Denda, Tadamichi, Kudo, Toshihiro, Okamoto, Wataru, Taniguchi, Hiroya, Akagi, Kiwamu, Kajiwara, Takeshi, Hironaka, Shuichi, Satoh, Taroh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486202/
https://www.ncbi.nlm.nih.gov/pubmed/26137573
http://dx.doi.org/10.1016/j.ebiom.2015.02.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486202/
https://www.ncbi.nlm.nih.gov/pubmed/26137573
http://dx.doi.org/10.1016/j.ebiom.2015.02.007

Ejemplares similares